Therefore, we produced an antibody recognizing the tumor-associated antigen CSPG4, as this cell surface neural crest antigen is over-expressed in a large proportion (~70–80%) of melanotic and other solid tumors, and it is found on cells likely to confer an aggressive phenotype [20,22,23]. This evidence concerns the gene CSPG4 and neoplasm.